Myeloma can affect anyone, but not all patient groups have optimal outcomes or receive the same level of care. For example, myeloma is the leading blood cancer in the Black community. Black patients make up 20 percent of the approximately 34,000 people diagnosed with myeloma annually in the United States. Despite the high incidence of myeloma in the Black community, most Black patients are diagnosed later when compared to other patient populations. They are also underrepresented in the research and clinical studies that are driving new treatments. In addition, increases in survival rates for Black patients have not kept pace with improved survival rates seen in other patient populations.
Racial and ethnic health disparities, social and financial disparities, and limited access to quality care are all contributing factors to the outcomes facing Black patients and other underserved populations in the myeloma community. Yet, research has shown that when Black myeloma patients experience a timely diagnosis and receive standard of care treatment, they can achieve the same, or better, disease outcomes as other myeloma patient populations.
Every myeloma patient deserves the best possible outcome. This belief is rooted in the MMRF’s mission to accelerate a cure for each and every patient. It also drives our deep commitment to diversity, equity, and inclusion, and specifically, our work to address disparities affecting underserved patients in the myeloma community.
Our goals focus on driving proportional patient representation in research and clinical studies, ending disparities affecting patient outcomes and access to standard of care through awareness and education, and building an organization and partner network that reflects the diverse community we serve.
"The MMRF is committed to diversity, equity, and inclusion as it is critical to achieving our mission of accelerating a cure for each and every myeloma patient. Building an inclusive workplace is a personal priority of mine. Our entire team is dedicated to pursuing more equitable outcomes for the entire myeloma community.”
The MMRF's Annual Health Equity Summit is a gathering of health officials, federal and local partners, and stakeholders devoted to the equitable delivery of healthcare, resources, research, and clinical trial participation across patients, employees, and all partners, no matter their race, ethnicity, gender, sexual orientation, or ability. Our work is centered on dialogue to inspire meaningful action to confront health disparities and root out causes to create more equitable healthcare delivery systems.
Email: [email protected]